New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Phibro Animal Health Corporation
PAHC
Shape
US Flag

NASDAQ

954M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

954M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Nov 2024

23.57USD
Shape0.15 ( 0.66%)
Market Open
favorite-chart

Relative Strenght

94
favorite-chart

Volume Buzz

-90%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

6%

Quote Panel

Shape
Updated October 25, 2024
1W -0.04 % 1M 6.97 % 3M 25.95 % 1Y 124.93 %

Key Metrics

Shape
  • Market Cap

    954.47M


  • Shares Outstanding

    40.50M


  • Share in Float

    39.75M


  • Dividende

    0.48


  • Earning Date

    13 Nov 2024


  • Price Target

    23.565


  • Average Volume

    188965


  • Beta

    0.52


  • Range

    9.4-25.11


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.pahc.com


  • Sector

    Healthcare


Fundamentals

Shape

19.87x

P/E Ratio

0.93x

P/S Ratio

3.69x

P/B Ratio

1.9

Debt/Equity

0.2%

Net Margin

$0.1

EPS

How PAHC compares to sector?

P/E Ratio

Relative Strength

Shape

PAHC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape331%

2025-Revenue

$1.20

Shape6352%

2025-EPS

$110M

Shape405%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Roth Capital

initialise

Previous: Not converted

2022-12-21

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-16%

0.21
vs 0.25

Q4.22

arrow
arrow

-8%

0.34
vs 0.37

Q1.23

arrow
arrow

-12%

0.29
vs 0.33

Q2.23

arrow
arrow

+6%

0.38
vs 0.36

Q3.23

arrow
arrow

-33%

0.14
vs 0.21

Q4.23

arrow
arrow

-3%

0.33
vs 0.34

Q1.24

arrow
arrow

+7%

0.31
vs 0.29

Q2.24

arrow
arrow

+8%

0.41
vs 0.38

Q3.24

arrow
arrow

+77%

0.25
vs 0.14

Q4.24

arrow
arrow

+24%

0.41
vs 0.33

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+8%

232.5M  vs 214.7M

Q4.22

arrow
arrow

+5%

244.6M  vs 232.7M

Q1.23

arrow
arrow

+3%

245.7M  vs 239.6M

Q2.23

arrow
arrow

0%

255M  vs 255.3M

Q3.23

arrow
arrow

-1%

231.3M  vs 232.5M

Q4.23

arrow
arrow

+2%

249.9M  vs 244.6M

Q1.24

arrow
arrow

+7%

263.2M  vs 245.7M

Q2.24

arrow
arrow

+7%

273.2M  vs 255M

Q3.24

arrow
arrow

+7%

246.7M  vs 231.3M

Q4.24

arrow
arrow

+15%

287.1M  vs 249.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+1%

0.01
vs 0.03

Q4.22

arrow
arrow

+3%

0.03
vs 0.01

Q1.23

arrow
arrow

+4%

0.04
vs 0.03

Q2.23

arrow
arrow

+4%

0.04
vs 0.04

Q3.23

arrow
arrow

-3%

-0.03
vs 0.04

Q4.23

arrow
arrow

+0%

0
vs -0.03

Q1.24

arrow
arrow

+3%

0.03
vs 0

Q2.24

arrow
arrow

+0%

0
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

143

143
vs 144

-1%

Q4.22

arrow
arrow

132

132
vs 143

-8%

Q1.23

arrow
arrow

134

134
vs 132

2%

Q2.23

arrow
arrow

131

131
vs 134

-2%

Q3.23

arrow
arrow

125

125
vs 131

-5%

Q4.23

arrow
arrow

137

137
vs 125

10%

Q1.24

arrow
arrow

139

139
vs 137

1%

Q2.24

arrow
arrow

140

140
vs 139

1%

Earnings Growth

Latest News